 ?您的位置：對(duì)照品 > 對(duì)照品 > 中藥對(duì)照品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：F591050 |
| 產(chǎn)品名稱：N-[(6S)-8-Fluoro-5,6-dihydro-4-(1-methylethyl)-6-[(2S,4R)-tetrahydro-6-oxo-2H-pyran-2-yl]b |
| 產(chǎn)品CAS： |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
F591050 |
| 名稱: |
N-[(6S)-8-Fluoro-5,6-dihydro-4-(1-methylethyl)-6-[(2S,4R)-tetrahydro-6-oxo-2H-pyran-2-yl]benzo[h]quinazolin-2-yl]-N-methylmethanesulfonamide O-tert-Butyldimethylsilyl Ether |
| 分子式: |
C??H??FN?O?SSi |
| 外觀: |
White foam |
| 分子量: |
577.78 |
| 儲(chǔ)存: |
冰箱保存 |
| 溶解度: |
Chloroform, Dichloromethane, Tetrahydrofuran |
| 種類: |
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
N-[(6S)-8-Fluoro-5,6-dihydro-4-(1-methylethyl)-6-[(2S,4R)-tetrahydro-6-oxo-2H-pyran-2-yl]benzo[h]quinazolin-2-yl]-N-methylmethanesulfonamide O-tert-Butyldimethylsilyl Ether is an intermediate in the synthesis of N-[(6S)-8-Fluoro-5,6-dihydro-4-(1-methylethyl)-6-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]benzo[h]quinazolin-2-yl]-N-methylmethanesulfonamide which is an impurity of the HMG-CoA reductase inhibitor Rosuvastatin (R700500). |
| 參考文獻(xiàn) |
|
|
|
|
|
|
![N-[(6S)-8-Fluoro-5,6-dihydro-4-(1-methylethyl)-6-[(2S,4R)-tetrahydro-6-oxo-2H-pyran-2-yl]b](/uploads/allimg/191202/1_1202012HGV9.png "N-[(6S)-8-Fluoro-5,6-dihydro-4-(1-methylethyl)-6-[(2S,4R)-tetrahydro-6-oxo-2H-pyran-2-yl]b")
